While the growth in U.S. healthcare costs is receiving substantial attention, many believe that instead of looking at general contributors, i.e. pharmaceutical pricing, we should look to resource allocation. Could Comparative Effectiveness Research (CER) methods help to answer this or is something different needed? Learn more here. (Source: Robert W Dubois, Future Medicine, Nov 2016)
You are here: / / Can Traditional CER Address Resource Allocation?